Biotoxtech Co. Ltd (086040) — Capital Reinvestment Ratio
Latest as of June 2025:
0.13x
Biotoxtech Co. Ltd (086040) has a Capital Reinvestment Ratio of 0.13x as of June 2025, meaning it reinvests 0% of its operating cash flow (₩649.06 Million) in capital expenditures (₩84.65 Million). See 086040 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.13x
Capex / Operating Cash Flow
Operating Cash Flow
₩649.06 Million
KRW
Capital Expenditures
₩84.65 Million
KRW
Data as of
Jun 2025
Most recent filing
Biotoxtech Co. Ltd Capital Reinvestment Ratio (2011–2021)
This chart tracks Biotoxtech Co. Ltd's Capital Reinvestment Ratio across 8 annual periods.
Annual Capital Reinvestment Ratio for Biotoxtech Co. Ltd (2011–2021)
Year-by-year Capital Reinvestment Ratio for Biotoxtech Co. Ltd from 2011 to 2021. For live market cap and broader valuation context, see Biotoxtech Co. Ltd (086040) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 1.75x | ₩4.35 Billion | ₩7.62 Billion | ▲ +485.5% |
| 2020 | 0.30x | ₩4.56 Billion | ₩1.37 Billion | ▼ -3.8% |
| 2019 | 0.31x | ₩1.44 Billion | ₩449.34 Million | ▼ -58.9% |
| 2018 | 0.76x | ₩3.06 Billion | ₩2.32 Billion | ▲ +33.8% |
| 2017 | 0.57x | ₩6.02 Billion | ₩3.41 Billion | ▲ +508.3% |
| 2016 | 0.09x | ₩5.28 Billion | ₩491.52 Million | ▼ -91.8% |
| 2012 | 1.13x | ₩1.63 Billion | ₩1.85 Billion | ▲ +25.5% |
| 2011 | 0.90x | ₩3.28 Billion | ₩2.96 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow